ArticleMolecular medicine reports2025

Solamargine inhibits gastric cancer progression via inactivation of STAT3/PD‑L1 signaling.

Xiongxiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.